Albert Maguire, MD
Retina Specialist · Philadelphia, PANPI 1235298209
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,668 of the $8,527 with a category attached, or 89.9%. Novartis accounts for 89.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $6,693 and has fallen 87.2% since, to $859 in 2022.
Across 3 payments — averaging $2842.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$8K
- Alcon$859
Across 220 payments — averaging $18,682 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Spark Therapeutics, Inc.$4.1M
What the payments were for
- Consulting fees$7,66890%
- Travel & lodging$85910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,527 in reported general payments places this provider in the 85th percentile of 43 retina specialist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 270 | $6,043 |
| Prednisolone Acetate | 114 | $5,616 |
| Difluprednate | 20 | $2,365 |
| Fluorometholone | 15 | $1,556 |
| Flurbiprofen Sodium | 12 | $373 |
| Latanoprost | 25 | $281 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $274 |
| Diclofenac Sodium | 30 | $248 |
| Brimonidine Tartrate | 20 | $179 |
| ErythromycinErythromycin Base | 15 | $163 |
| Dorzolamide Hcl | 12 | $92 |
| Timolol Maleate | 13 | $89 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Philadelphia
- Joshua GreenePhiladelphia$394K
- Brian VanderbeekPhiladelphia$14K
- Hugo LinaresPhiladelphia$7K
- Benjamin KimPhiladelphia$5K
- Tomas AlemanPhiladelphia$3K
- Robert CarrollPhiladelphia$1K
- Drew ScolesPhiladelphia$519
- Juan GrunwaldPhiladelphia$508
- Alexander BruckerPhiladelphia$86
- William FosterPhiladelphia$28
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.